Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Jan;68(1 Spec No):3–5. doi: 10.1136/adc.68.1_spec_no.3

Screening for toxoplasmosis during pregnancy.

C S Peckham 1, S Logan 1
PMCID: PMC1029156  PMID: 8439194

Full text

PDF
3

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E. Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy. Epidemiol Infect. 1991 Dec;107(3):527–535. doi: 10.1017/s0950268800049220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ades A. E. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect. 1992 Apr;108(2):367–375. doi: 10.1017/s0950268800049839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Couvreur J., Desmonts G., Thulliez P. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrob Chemother. 1988 Jul;22 (Suppl B):193–200. doi: 10.1093/jac/22.supplement_b.193. [DOI] [PubMed] [Google Scholar]
  4. Daffos F., Capella-Pavlovsky M., Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol. 1985 Nov 15;153(6):655–660. doi: 10.1016/s0002-9378(85)80254-4. [DOI] [PubMed] [Google Scholar]
  5. Desmonts G., Daffos F., Forestier F., Capella-Pavlovsky M., Thulliez P., Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet. 1985 Mar 2;1(8427):500–504. doi: 10.1016/s0140-6736(85)92096-3. [DOI] [PubMed] [Google Scholar]
  6. Forsgren M., Gille E., Ljungström I., Nokes D. J. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet. 1991 Jun 8;337(8754):1413–1414. doi: 10.1016/0140-6736(91)93095-q. [DOI] [PubMed] [Google Scholar]
  7. Hall S. M., Glickman M. Report from the British Paediatric Surveillance Unit. Arch Dis Child. 1990 Jul;65(7):807–809. doi: 10.1136/adc.65.7.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jeannel D., Costagliola D., Niel G., Hubert B., Danis M. What is known about the prevention of congenital toxoplasmosis? Lancet. 1990 Aug 11;336(8711):359–361. doi: 10.1016/0140-6736(90)91890-m. [DOI] [PubMed] [Google Scholar]
  9. Joss A. W., Chatterton J. M., Ho-Yen D. O. Congenital toxoplasmosis: to screen or not to screen? Public Health. 1990 Jan;104(1):9–20. doi: 10.1016/s0033-3506(05)80340-3. [DOI] [PubMed] [Google Scholar]
  10. Koppe J. G., Rothova A. Congenital toxoplasmosis. A long-term follow-up of 20 years. Int Ophthalmol. 1989 Dec;13(6):387–390. doi: 10.1007/BF02306486. [DOI] [PubMed] [Google Scholar]
  11. Marteau T. M. Screening in practice: Reducing the psychological costs. BMJ. 1990 Jul 7;301(6742):26–28. doi: 10.1136/bmj.301.6742.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Walker J., Nokes D. J., Jennings R. Longitudinal study of Toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect. 1992 Feb;108(1):99–106. doi: 10.1017/s0950268800049542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wilson C. B., Remington J. S., Stagno S., Reynolds D. W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767–774. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES